Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 305 | 2,402 | 1,854 | 201 | 1,432 |
| Operating Expenses | 6,763 | 7,175 | 5,083 | 4,599 | 5,517 |
| Operating Income | -6,458 | -4,773 | -3,229 | -4,398 | -4,085 |
| Interest Expense | 134 | N/A | N/A | N/A | N/A |
| Other Income | 251 | 386 | 486 | 696 | 754 |
| Pre-tax Income | -6,341 | -4,388 | -2,743 | -3,702 | -3,331 |
| Income Tax | -671 | -316 | -354 | -514 | -427 |
| Net Income Continuous | -5,670 | -4,071 | -2,389 | -3,188 | -2,904 |
| Net Income | $-5,670 | $-4,071 | $-2,389 | $-3,188 | $-2,904 |
| EPS Basic Total Ops | -5.51 | -4.27 | -2.76 | -4.09 | -3.78 |
| EPS Basic Continuous Ops | -5.51 | -4.27 | -2.76 | -4.09 | -3.78 |
| EPS Diluted Total Ops | -5.51 | -4.27 | -2.76 | -4.09 | -3.78 |
| EPS Diluted Continuous Ops | -5.51 | -4.27 | -2.76 | -4.09 | -3.78 |
| EBITDA(a) | $-6,134 | $-4,695 | $-3,139 | $-4,337 | $-4,042 |